Ticagrelor

Benefits of Ticagrelor

Prevention of Heart Attacks and Strokes: Ticagrelor significantly reduces the risk of subsequent heart attacks or strokes in patients with acute coronary syndrome (ACS) or those who have undergone coronary stent procedures.
Faster and More Potent Effect: As a direct P2Y12 receptor antagonist, Ticagrelor provides a more immediate and potent antiplatelet effect compared to Clopidogrel and other older antiplatelet medications.
Reduced Risk of Thrombosis: Ticagrelor has been shown to lower the likelihood of thrombosis (blood clot formation), which can lead to fatal cardiovascular events such as heart attacks, strokes, and complications following coronary artery procedures.
Improved Outcomes After Stenting: Ticagrelor is commonly prescribed for patients following stent implantation to prevent blood clotting inside the stent, reducing the risk of stent thrombosis and ensuring long-term success of the procedure.

How is Ticagrelor Used?

Ticagrelor is typically prescribed in combination with aspirin as part of dual antiplatelet therapy (DAPT). The usual dosage is 90 mg twice a day, although it may vary based on individual patient needs and healthcare provider recommendations.

Ticagrelor is most often used for:

Patients with Acute Coronary Syndrome (ACS): Ticagrelor is often prescribed to patients who are experiencing unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI), or those recovering from a ST-segment elevation myocardial infarction (STEMI).
Post-Myocardial Infarction (MI) Patients: For patients who have had a heart attack, Ticagrelor helps prevent recurrent heart attacks and other cardiovascular events.
Post-Stent Implantation: Ticagrelor is frequently used in combination with aspirin after coronary stent placement to prevent stent thrombosis and improve the overall success of the procedure.

Who Should Take Ticagrelor?

Ticagrelor is generally prescribed to individuals who have been diagnosed with coronary artery disease or other cardiovascular conditions and are at risk for thrombotic events. The following individuals are most likely to benefit from Ticagrelor therapy:

Patients with Acute Coronary Syndrome (ACS): Those with unstable angina or who are recovering from a heart attack.
Patients Post-Stenting: Individuals who have had a stent placed to open up blocked coronary arteries.
People with a History of Heart Disease: Those who have had previous heart attacks or coronary artery disease.

However, Ticagrelor may not be suitable for everyone. It should not be used by people with active bleeding, a history of intracranial hemorrhage, or severe liver impairment. Always consult a healthcare provider to determine if Ticagrelor is the right treatment for your condition.

Common Side Effects of Ticagrelor

While Ticagrelor is generally well tolerated, like all medications, it can cause side effects in some patients. Common side effects include:

Bleeding: Due to its blood-thinning properties, Ticagrelor can increase the risk of bleeding, including nosebleeds, bruising, and bleeding in the gastrointestinal tract.
Dyspnea (Shortness of Breath): Some patients report shortness of breath, especially in the first few days of treatment.
Bradycardia (Slow Heart Rate): Ticagrelor can cause a decrease in heart rate, particularly during the first few days of therapy.
Gastrointestinal Issues: Some individuals may experience nausea, diarrhea, or indigestion.

Serious side effects are rare but can include life-threatening bleeding. If you notice unusual bleeding or bruising, or if you experience severe side effects, contact your healthcare provider immediately.

Interested in learning more about how Ticagrelor can help manage your cardiovascular health?

Contact us today to speak with a healthcare professional and discuss your treatment options.

Contact